Laurent Vandebrouck
About
Laurent Vandebrouck is from Paris, Île-de-France, France. Laurent is currently CEO at Restorative Neurotechnologies, located in Palermo, Sicily, Italy. Laurent also works as CEO (Chief Executive Officer) at CHD (Connected Health Development), a job Laurent has held since Jan 2018.
You can find Laurent Vandebrouck's email at finalscout.com. FinalScout is a professional database with business professional profiles and company profiles.
Laurent Vandebrouck's current jobs
Restorative Neurotechnologies is a pioneer in developing innovative medical devices and digital therapies for the neurorehabilitation of patients with cognitive impairment e.g. post-stroke, brain trauma, ADHD (Attention Deficit Hyperactivity Disorder). Restorative Neurotechnologies' flagship innovation, MindLenses Professional, is an end-to-end, patented digital therapy solution for cognitive rehabilitation, combining non-invasive neuromodulation (prismatic lenses) together with patient tablet applications and serious games developed by neurologists and psychologists, plus a suite of Web services providing Health Care Providers with access to clinical data and metrics on therapeutic outcomes. MindLenses Professional has proven strong clinical benefits and patient outcomes versus any other alternative in the cognitive rehabilitation market so far, with faster recovery times (2 weeks vs. 1 month of traditional pen-and-paper methods), and improvement up to 30% in attention, memory, and several other functions. Today, MindLenses is adopted by leading general hospitals and specialized neurorehabilitation centers in Italy, among which Ospedale Niguarda and San Paolo in Milan, IRCCS Fondazione Santa Lucia and Umberto I in Rome, and IRCCS Ospedale San Camillo in Venice, in addition to several private neurological practices, home cares and clinics. Currently a Class I medical device, MindLenses Professional will upgrade to Class IIa in Q1 24, allowing launch and commercialization in Europe through a network of distributors and resellers. Additional clinical trials will be launched in Italy in 2024 to expand MindLenses' intended use to learning disabilities (dyslexia) and neurodegenerative diseases (Alzheimer's). Restorative Neurotechnologies is supported by leading investors and shareholders from the Italian healthcare eco-system (CDP, Italian Angels for Growth, SocialFare,...) and has recently launched a fund raising to launch and accelerate its global growth.
CHD supports the Medtech, Pharma and Insurers to define, develop and launch their connected and digital health service offering for RPM (Remote Patient Monitoring), prevention and/or therapeutic efficiency programs